PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global pandemic. The prevalence/severity of COVID-19 is higher among patients with cardiovascular risk factors. Despite the expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 infection, in cardiomyocytes, there has been no conclusive evidence of direct viral infection although the presence of viral genome within COVID-19 patients’ hearts has been reported. Here, we overexpressed SARS-CoV-2 genes in A549 lung epithelial cells. We then isolated extracellular vesicles (EVs) and detected the presence of viral RNA within these EVs. We observed that human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are receptive to these EVs, and viral genes were detectable in the cardiomyocytes. Accordingly, the uptake of viral RNA-harboring EVs led to an upregulation of inflammation-related genes in hiPSC-CMs. Thus, our findings indicate that SARS-CoV-2 RNA containing EVs represents an indirect route of viral RNA entry into cardiomyocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-020-02033-7.
is ?:annotates of
?:creator
?:doi
  • 10.1186/s13287-020-02033-7
?:doi
?:journal
  • Stem_Cell_Res_Ther
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/f417cfb63d4594ee70de42290ded7d91e7a691ff.json
?:pmcid
?:pmid
?:pmid
  • 33256833.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells
?:type
?:year
  • 2020-11-30

Metadata

Anon_0  
expand all